R. Elisei

Involvement of protein kinase Cepsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis.

X. Chen, J. Korenberg, J. Fagin, 1999, The Journal of biological chemistry.

Definition and management of radioactive iodine-refractory differentiated thyroid cancer.

M. Luster, M. Schlumberger, M. Brose, 2014, The lancet. Diabetes & endocrinology.

Molecular biology studies on mesothelioma tumor samples: preliminary data on H-ras, p21, and SV40.

A. Vivaldi, A. Cristaudo, G. Guglielmi, 1995, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

Anaplastic thyroid cancer: prevalence, diagnosis and treatment.

D. Rubello, G. Mariani, R. Elisei, 2008, Minerva endocrinologica.

The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway

J. Fagin, H. Saavedra, P. Stambrook, 2000, Oncogene.

Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets.

J. Fagin, J. Knauf, R. Gonsky, 1997, Nucleic acids research.

A JOINT STATEMENT FROM THE AMERICAN THYROID ASSOCIATION.

Frederick D. Grant, W. Oyen, L. Hegedüs, 2021, Thyroid : official journal of the American Thyroid Association.

Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation.

J. Fagin, J. Gross, G. Medeiros-Neto, 1996, The Journal of clinical endocrinology and metabolism.

Conditional apoptosis induced by oncogenic ras in thyroid cells.

J. Fagin, T. Hara, H. Saavedra, 2000, Molecular endocrinology.

Cabozantinib: an orphan drug for thyroid cancer

R. Elisei, S. Mazzeo, V. Cappagli, 2015 .